ACTA1 and kidney disorder: In more detail, dapagliflozin in a dose-dependent manner prevented the expression of αSMA (alpha-smooth muscle actin) in glomerular mesangial and tubular epithelial cells (abundant expression of αSMA in kidney diseases is a marker of cell dedifferentiation and a change of the phenotype into the proinflammatory and profibrotic one).